HUMA · Humacyte, Inc. · Documents
$0.44
+0.02 (+5.40%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company will not have sufficient liquidity to fund its operations beyond one year from the issuance of these condensed consolidated financial statements if the Company is unable to generate sufficient cash flows from commercial sales on a timely basis and/or obtain additional capital. These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$120.95M
Shares
277.80M
Volume · Oct 23
2.61M
Avg daily vol (3M)
6.43M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-08-25 | 2021-08-24 | |
| 8-K | — | 2021-08-17 | — | |
| 10-Q | — | 2021-08-16 | 2021-06-30 | |
| 8-K | — | 2021-08-04 | — | |
| S-4/A | — | 2021-08-02 | — | |
| S-4/A | — | 2021-07-23 | — | |
| S-4/A | — | 2021-07-01 | — | |
| S-4/A | — | 2021-06-14 | — | |
| 8-K | — | 2021-06-07 | 2021-06-04 | |
| 8-K | — | 2021-05-26 | 2021-05-22 | |
| 8-K | — | 2021-05-21 | — | |
| 8-K | — | 2021-05-20 | 2021-05-19 | |
| 10-Q | — | 2021-05-17 | 2021-03-31 | |
| 10-K/A | — | 2021-05-14 | 2020-12-31 | |
| 8-K | — | 2021-05-13 | 2021-05-07 | |
| 8-K | — | 2021-05-06 | — | |
| 8-K | — | 2021-04-21 | — | |
| 8-K | — | 2021-04-14 | 2021-03-05 | |
| S-4 | — | 2021-03-23 | — | |
| 8-K | — | 2021-03-05 | — | |
| 8-K | — | 2021-02-17 | — | |
| 8-K | — | 2021-02-17 | — | |
| 10-K | — | 2021-02-16 | 2020-12-31 | |
| 10-Q | — | 2020-11-13 | 2020-09-30 | |
| 8-K | — | 2020-11-06 | — | |
| 8-K | — | 2020-09-28 | 2020-09-22 | |
| 8-K | — | 2020-09-22 | 2020-09-17 | |
| S-1/A | — | 2020-09-14 | — | |
| S-1/A | — | 2020-09-01 | — | |
| S-1 | — | 2020-08-04 | — |
Showing 101–130 of 130 filings
Key facts
CIK
1818382
CUSIP
44486Q103
13F (30d)
24 filings
24 filers
Visit website
Investor relations